Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Morata

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|May 13, 2021
Experience with the use of siltuximab in patients with SARS-CoV-2 infectionF Meira, L Albiach, C Carbonell, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2019
Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint InfectionsL Morata, J Cobo, M Fernández-Sampedro, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|April 8, 2021
Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infectionE Moreno-García, E Rico, L Albiach, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|May 13, 2021
Experience with the use of siltuximab in patients with SARS-CoV-2 infectionF Meira, L Albiach, C Carbonell, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2019
Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint InfectionsL Morata, J Cobo, M Fernández-Sampedro, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|April 8, 2021
Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infectionE Moreno-García, E Rico, L Albiach, et al.
Pageof 4